Monopar Therapeutics Inc

MNPR NASDAQ Santé & Biotech États-Unis US61023L1089
59.27 $
2.82 %

Monopar Therapeutics Inc est une société biopharmaceutique en développement qui se concentre sur les traitements contre le cancer et les maladies graves connexes.

Performance & Momentum

6 Months 22.45 %
1 Year 59.50 %
3 Years 1 291 %
5 Years 107.96 %

Similar stocks to Monopar Therapeutics Inc

Anantys Community

Be the first to share your analysis on Monopar Therapeutics Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases